Trial Profile
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors, Independent Investigator Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Schizoaffective disorder; Schizophrenia; Smoking withdrawal
- Focus Therapeutic Use
- 19 Nov 2014 New trial record